...
cdxc-img

Chromadex Corp, Common Stock

CDXC

NAQ

$7.61

+$0.05

(0.66%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$577.46M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
378
Volume info-icon
This is the total number of shares traded during the most recent trading day.
596.32K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.88
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.32 L
$7.97 H
$7.61

About Chromadex Corp, Common Stock

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameCDXCSectorS&P500
1-Week Return0.26%0.67%0.49%
1-Month Return32.58%0.26%5.96%
3-Month Return132.01%-6.21%9.35%
6-Month Return159.73%1.69%14.4%
1-Year Return443.57%11.41%32.23%
3-Year Return74.94%12.87%33.15%
5-Year Return113.76%48.89%95.23%
10-Year Return139.31%109.26%191.11%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue46.29M59.26M67.45M72.05M83.57M[{"date":"2019-12-31","value":55.39,"profit":true},{"date":"2020-12-31","value":70.91,"profit":true},{"date":"2021-12-31","value":80.71,"profit":true},{"date":"2022-12-31","value":86.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue20.52M23.98M25.96M29.25M32.79M[{"date":"2019-12-31","value":62.59,"profit":true},{"date":"2020-12-31","value":73.14,"profit":true},{"date":"2021-12-31","value":79.17,"profit":true},{"date":"2022-12-31","value":89.21,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit25.77M35.27M41.49M42.80M50.78M[{"date":"2019-12-31","value":50.75,"profit":true},{"date":"2020-12-31","value":69.46,"profit":true},{"date":"2021-12-31","value":81.71,"profit":true},{"date":"2022-12-31","value":84.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin55.67%59.53%61.51%59.40%60.76%[{"date":"2019-12-31","value":90.5,"profit":true},{"date":"2020-12-31","value":96.77,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.56,"profit":true},{"date":"2023-12-31","value":98.78,"profit":true}]
Operating Expenses57.07M55.13M68.56M61.42M56.38M[{"date":"2019-12-31","value":83.24,"profit":true},{"date":"2020-12-31","value":80.4,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.59,"profit":true},{"date":"2023-12-31","value":82.23,"profit":true}]
Operating Income(31.30M)(19.85M)(27.07M)(18.63M)(5.60M)[{"date":"2019-12-31","value":-3130000000,"profit":false},{"date":"2020-12-31","value":-1985400000,"profit":false},{"date":"2021-12-31","value":-2707300000,"profit":false},{"date":"2022-12-31","value":-1862800000,"profit":false},{"date":"2023-12-31","value":-559900000,"profit":false}]
Total Non-Operating Income/Expense(1.69M)(142.00K)(110.00K)2.09M1.07M[{"date":"2019-12-31","value":-81.01,"profit":false},{"date":"2020-12-31","value":-6.79,"profit":false},{"date":"2021-12-31","value":-5.26,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":50.98,"profit":true}]
Pre-Tax Income(32.15M)(19.93M)(27.13M)(16.54M)(4.94M)[{"date":"2019-12-31","value":-3214700000,"profit":false},{"date":"2020-12-31","value":-1992500000,"profit":false},{"date":"2021-12-31","value":-2712800000,"profit":false},{"date":"2022-12-31","value":-1654000000,"profit":false},{"date":"2023-12-31","value":-493800000,"profit":false}]
Income Taxes(676.00K)(1.44M)(1.57M)(2.09M)1.54M[{"date":"2019-12-31","value":-43.98,"profit":false},{"date":"2020-12-31","value":-93.81,"profit":false},{"date":"2021-12-31","value":-102.21,"profit":false},{"date":"2022-12-31","value":-136.03,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(31.47M)(18.48M)(25.56M)(14.45M)(6.48M)[{"date":"2019-12-31","value":-3147100000,"profit":false},{"date":"2020-12-31","value":-1848300000,"profit":false},{"date":"2021-12-31","value":-2555700000,"profit":false},{"date":"2022-12-31","value":-1444900000,"profit":false},{"date":"2023-12-31","value":-647510500,"profit":false}]
Income From Continuous Operations(32.15M)(19.93M)(27.13M)(18.63M)(6.47M)[{"date":"2019-12-31","value":-3214700000,"profit":false},{"date":"2020-12-31","value":-1992500000,"profit":false},{"date":"2021-12-31","value":-2712800000,"profit":false},{"date":"2022-12-31","value":-1862500000,"profit":false},{"date":"2023-12-31","value":-647000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(31.47M)(18.48M)(25.56M)(14.45M)(4.94M)[{"date":"2019-12-31","value":-3147100000,"profit":false},{"date":"2020-12-31","value":-1848300000,"profit":false},{"date":"2021-12-31","value":-2555700000,"profit":false},{"date":"2022-12-31","value":-1444900000,"profit":false},{"date":"2023-12-31","value":-493800000,"profit":false}]
EPS (Diluted)(0.55)(0.33)(0.41)(0.26)(0.07)[{"date":"2019-12-31","value":-55,"profit":false},{"date":"2020-12-31","value":-33,"profit":false},{"date":"2021-12-31","value":-41,"profit":false},{"date":"2022-12-31","value":-26,"profit":false},{"date":"2023-12-31","value":-6.85,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CDXC
Cash Ratio 1.83
Current Ratio 2.95
Quick Ratio 2.35

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CDXC
ROA (LTM) 0.51%
ROE (LTM) 4.82%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CDXC
Debt Ratio Lower is generally better. Negative is bad. 0.39
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.61

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CDXC
Trailing PE 380.50
Forward PE 58.14
P/S (TTM) 6.34
P/B 16.80
Price/FCF 168
EV/R 5.98
EV/Ebitda 281.66
PEG NM

FAQs

What is Chromadex Corp share price today?

Chromadex Corp (CDXC) share price today is $7.61

Can Indians buy Chromadex Corp shares?

Yes, Indians can buy shares of Chromadex Corp (CDXC) on Vested. To buy Chromadex Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CDXC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Chromadex Corp be purchased?

Yes, you can purchase fractional shares of Chromadex Corp (CDXC) via the Vested app. You can start investing in Chromadex Corp (CDXC) with a minimum investment of $1.

How to invest in Chromadex Corp shares from India?

You can invest in shares of Chromadex Corp (CDXC) via Vested in three simple steps:

  • Click on Sign Up or Invest in CDXC stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Chromadex Corp shares
What is Chromadex Corp 52-week high and low stock price?

The 52-week high price of Chromadex Corp (CDXC) is $7.97. The 52-week low price of Chromadex Corp (CDXC) is $1.32.

What is Chromadex Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Chromadex Corp (CDXC) is 378

What is Chromadex Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Chromadex Corp (CDXC) is 16.80

What is Chromadex Corp dividend yield?

The dividend yield of Chromadex Corp (CDXC) is 0.00%

What is the Market Cap of Chromadex Corp?

The market capitalization of Chromadex Corp (CDXC) is $577.46M

What is Chromadex Corp’s stock symbol?

The stock symbol (or ticker) of Chromadex Corp is CDXC

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top